Zwick Jordan Michael 4
4 · PALISADE BIO, INC. · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
Palisade Bio (PALI) Director Zwick Jordan Michael Receives RSU Award
What Happened
Zwick Jordan Michael, a director of Palisade Bio, was awarded 336,904 restricted stock units (RSUs) on June 10, 2026. The RSUs were reported as an award (Form 4 code A); no purchase price is listed because RSUs are a grant of contingent rights to receive shares upon vesting, not an open‑market purchase or sale.
Key Details
- Transaction date: 2026-06-10; Form 4 filed 2026-06-12 (filed within the normal two-business-day reporting window).
- Award size: 336,904 RSUs. Price: N/A (RSU grant).
- Vesting: RSUs vest in three equal annual installments; the first installment vests on the one‑year anniversary of the grant (i.e., ~June 10, 2027), subject to the reporting person’s continuous service.
- Shares owned after transaction: not disclosed in the filing.
- Footnote: each RSU represents a contingent right to one share of common stock upon vesting.
Context
RSU awards are compensation, common for directors and executives; they do not create immediate voting power or saleable shares until vested and delivered. This award should be viewed as a grant of future equity rather than an active buy or sell signal.
Insider Transaction Report
Form 4
Zwick Jordan Michael
Director
Transactions
- Award
Common Stock
[F1]2026-06-10+336,904→ 336,904 total
Footnotes (1)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the anniversary of June 10, 2026, subject to the Reporting Person's continuous service with the Issuer through such date.
Signature
/s/ Ryker Willie, Attorney-in-Fact for Jordan Michael Zwick|2026-06-12